Baudax Bio, Inc.
BXRXDelisted Feb 15, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001780097
Baudax Bio, Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Dec 19, 2022; 15 institutions reported holding it in 13F filings for Q3 2023, worth $74.5K in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Baudax Bio, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
BXRX is no longer listed, so this page shows Q3 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 15
- +3 vs. Q2 2023
- Shares held
- 199.8K
- +69.9K (+53.8%) vs. Q2 2023
- Total value
- $74.5K
- −$77.6K (−51.0%) vs. Q2 2023
- New holders
- 5
- 3 more added
- Sold out
- 2
- 1 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 2 | $0 |
| Q3 2023 | 15 | $74.5K |
| Q2 2023 | 12 | $152.0K |
| Q1 2023 | 12 | $127.0K |
| Q4 2022 | 10 | $73.2K |
| Q3 2022 | 22 | $352.0K |
| Q2 2022 | 22 | $1.08M |
| Q1 2022 | 21 | $2.20M |
| Q4 2021 | 33 | $2.78M |
| Q3 2021 | 31 | $4.12M |
| Q2 2021 | 39 | $5.58M |
| Q1 2021 | 38 | $9.43M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Baudax Bio, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Sittner & Nelson, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 1 | $0 | 0.00% | +1 | New |
| Group One Trading, L.P. | 4 | $1 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 22 | $6 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 53 | $20 | 0.00% | +9+20.5% | Added |
| BlackRock Inc. | 797 | $295 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,844 | $2.53K | 0.00% | −2,812−29.1% | Reduced |
| Susquehanna International Group, LLP | 10,699 | $3.96K | 0.00% | +10,699 | New |
| Tower Research Capital LLC (TRC) | 10,834 | $4.01K | 0.00% | +276+2.6% | Added |
| State Street Corp | 11,602 | $4.29K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 23,426 | $8.67K | 0.00% | +23,426 | New |
| Virtu Financial LLC | 41,888 | $16.0K | 0.00% | +41,888 | New |
| Geode Capital Management, LLC | 45,363 | $16.8K | 0.00% | +45,363 | New |
| Vanguard Group Inc | 48,300 | $17.9K | 0.00% | +23,400+94.0% | Added |
| Creative Planning | 0 | $0 | 0.00% | −45,001−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −27,342−100.0% | Sold out |